Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03413969 · ClinicalTrials.gov registry record · NA
Building Physician Resiliency Through CREATION Health: A Research Study
A NA study, sponsored by AdventHealth.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03413969: Clinical Trial NA study, sponsored by AdventHealth.
NCT03413969 is a NA study that was terminated before completion, run by AdventHealth. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03413969, a NA study, was terminated before completion, sponsored by AdventHealth.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a standardized application of a physician-oriented CREATION Health curriculum is associated with reductions in burnout and perceived stress and improvements in well-being and empathy
Primary Outcome
The Emotional Exhaustion subscale scores range from 0 to 54. Higher scores indicate worse outcomes. The Depersonalization subscale scores range from 0 to 30. Higher scores indicate worst outcomes. The Personal Accomplishment subscale scores range from 0 to 48. Higher scores indicate better outcomes.
Interventions
- BEHAVIORAL CREATION
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2018-03-20 |
| Est. Completion | 2019-03-28 |
| Phase | NA |
Why NCT03413969 stopped before completion
NCT03413969 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which CREATION is the first listed.
NCT03413969 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03413969 about?
NCT03413969 is a clinical study titled "Building Physician Resiliency Through CREATION Health: A Research Study". The purpose of this study is to determine whether a standardized application of a physician-oriented CREATION Health curriculum is associated with reductions in burnout and perceived stress and improvements in well-being and empathy
What is the current status of trial NCT03413969?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2018-03-20. Estimated completion is 2019-03-28.
What interventions are being tested in trial NCT03413969?
The interventions under investigation include: CREATION (BEHAVIORAL).
Who is sponsoring clinical trial NCT03413969?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03413969's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI